Pages that link to "Q48825408"
Jump to navigation
Jump to search
The following pages link to Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications (Q48825408):
Displaying 50 items.
- The human sympathetic nervous system: its relevance in hypertension and heart failure (Q28264609) (← links)
- Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial (Q28553172) (← links)
- Pathophysiology of sleep apnea (Q30440658) (← links)
- Selective indication for positive airway pressure (PAP) in sleep-related breathing disorders with obstruction (Q30473014) (← links)
- Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report (Q30477320) (← links)
- SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS (Q30494316) (← links)
- Effect of treatment by laser-assisted uvulopalatoplasty on cardiopulmonary exercise test in obstructive sleep apnea syndrome (Q33219717) (← links)
- Snoring and sleep apnea. A study of evolution and consequences in a male population. Minireview based on a doctoral thesis (Q33537578) (← links)
- Sleep apnoea and snoring: potential links with vascular disease (Q33588178) (← links)
- Sleep apnoea in women (Q33588184) (← links)
- CPAP therapy: outcomes and patient use. (Q33588221) (← links)
- Effects of hypoxia on sympathetic neural control in humans (Q34017523) (← links)
- Understanding the metabolic syndrome: a modeling perspective (Q34129723) (← links)
- Functional and structural changes in the brain associated with the increase in muscle sympathetic nerve activity in obstructive sleep apnoea (Q34432300) (← links)
- Sleep apnea and cardiovascular disease (Q34467343) (← links)
- Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension (Q34487311) (← links)
- Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis (Q34542904) (← links)
- Chemoreflexes, sleep apnea, and sympathetic dysregulation (Q34598170) (← links)
- Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea (Q34622369) (← links)
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome (Q34622523) (← links)
- Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processing (Q34624915) (← links)
- Sleep disordered breathing--a new component of syndrome x? (Q34742776) (← links)
- Chronic intermittent hypoxia increases blood pressure and expression of FosB/DeltaFosB in central autonomic regions (Q35086929) (← links)
- Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity (Q35136210) (← links)
- Sleep-disordered breathing, glucose intolerance, and insulin resistance (Q35174358) (← links)
- Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension. (Q35536399) (← links)
- Insulin Resistance and Obstructive Sleep Apnea: Is Increased Sympathetic Stimulation the Link? (Q35553036) (← links)
- Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea (Q35646020) (← links)
- Reversal of functional changes in the brain associated with obstructive sleep apnoea following 6 months of CPAP (Q35693652) (← links)
- Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial (Q35879674) (← links)
- Modeling of autonomic control in sleep-disordered breathing (Q35919689) (← links)
- Brain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation. (Q38632622) (← links)
- Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis (Q36024087) (← links)
- Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? (Q36323458) (← links)
- Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea (Q36585652) (← links)
- Diagnostic and therapeutic approach to nonsleepy apnea (Q36790467) (← links)
- Serum angiotensin converting enzyme and the obstructive sleep apnea hypopnea syndrome (Q36890145) (← links)
- Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk (Q36891461) (← links)
- Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients (Q36997247) (← links)
- Molecular signatures of obstructive sleep apnea in adults: a review and perspective. (Q37146506) (← links)
- Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. (Q37161338) (← links)
- Sleep-related changes in autonomic control in obstructive sleep apnea: a model-based perspective (Q37185178) (← links)
- Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation? (Q37243305) (← links)
- The SomnuSeal Oral Mask Is Reasonably Tolerated by Otherwise CPAP Noncompliant Patients with OSA. (Q37280182) (← links)
- Hypertension and obstructive sleep apnoea syndrome: current perspectives (Q37364445) (← links)
- Hypertension and catecholamine levels in sleep apnoea (Q37390852) (← links)
- Association of cardiac autonomic function measures with severity of sleep-disordered breathing in a community-based sample (Q37415132) (← links)
- Mechanisms of sleep-disordered breathing: causes and consequences (Q37956196) (← links)
- The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? (Q38033647) (← links)
- Mechanisms of cardiac dysfunction in obstructive sleep apnea (Q38046075) (← links)